Pyridoxylamine
Pyridoxylamine is an advanced glycation end production (AGEs) and lipoxidation end products (ALEs) inhibitor, to protect against diabetes-induced retinal vascular lesions.
Product Specifications
CAS Number
[85-87-0]
UNSPSC
12352005
Hazard Statement
H302, H312, H332
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Pyridoxylamine.html
Concentration
10mM
Purity
99.91
Solubility
DMSO : 16.67 mg/mL (ultrasonic) |H2O : 6.25 mg/mL (ultrasonic)
Smiles
OCC1=C(CN)C(O)=C(C)N=C1
Molecular Formula
C8H12N2O2
Molecular Weight
168.19
Precautions
H302, H312, H332
References & Citations
[1]Stitt A, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes. 2002 Sep;51 (9) :2826-32.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
Phase 3
Isoform
Human Endogenous Metabolite
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
IL1RAP (Interleukin-1 Receptor Accessory Protein, IL-1 Receptor Accessory Protein, IL-1RAcP, Interleukin 1 Receptor AcP, C3orf13, FLJ37788, Interleukin-1 Receptor 3, IL1R3, IL-1R3, IL-1R-3) (FITC)